High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program

Prev Med. 2015 Dec:81:157-62. doi: 10.1016/j.ypmed.2015.08.018. Epub 2015 Sep 5.

Abstract

Objective: To determine the prevalence of cytological abnormalities and high risk Human PapillomaVirus (hrHPV) in cervical smears from French women aged over 65 years who attended the referent Gynecology Clinic of the Besançon University Hospital.

Methods: Between 2002 and 2012, 796 French women aged 66-99 years were cotested for cytology and hrHPV by Hybrid Capture 2 (hc2). hc2-positive cases were subjected to real time PCR for specific HPV 16/18/45 genotyping. Women with normal Pap smears and positive for hrHPV were followed-up every 12 months.

Results: Cytological abnormalities were detected in more than 30% of women and cervical cancers (CC) in 2.9% of women. Benign lesions were more frequent in women aged 66-75 years while (pre)-malignant lesions were preferentially found in women over 76. The prevalence of hrHPV was 22.7%. HPV 16 was the most frequent (23.8%), followed by HPV 45 (7.7%) and HPV 18 (3.9%). The rate of hrHPV increased with the lesion severity and HPV 16 was identified in 50% of CC. Among the followed-up women, those who developed CIN3 were HPV16 positive at study entry.

Conclusion: The study provides important estimates of the prevalence of cervical abnormalities and hrHPV positivity in a French hospital based-population over 65. Findings suggest to consider this high risk population in regards to cervical cancer.

Keywords: Cervical cancer; HPV 16; Pap smears; Women aged over 65; hrHPV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • DNA-Binding Proteins
  • Early Detection of Cancer*
  • Female
  • France / epidemiology
  • Genotype
  • Hospitalization
  • Human Papillomavirus DNA Tests
  • Humans
  • Mass Screening / methods
  • Papanicolaou Test
  • Papillomaviridae / genetics
  • Papillomaviridae / isolation & purification
  • Papillomavirus Infections / diagnosis*
  • Papillomavirus Infections / epidemiology
  • Prevalence
  • Retrospective Studies
  • Uterine Cervical Dysplasia / epidemiology*
  • Uterine Cervical Neoplasms / diagnosis*
  • Uterine Cervical Neoplasms / virology

Substances

  • DNA-Binding Proteins
  • PARPBP protein, human